Skip to search formSkip to main contentSkip to account menu

imolamine

Known as: 4-(2-(diethylamino)ethyl)-5-imino-3-phenyl- delta(2)-1,2,4-oxadiazoline 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (4)

Irri-CorIrrigorLA 1211imolamine hydrochloride

Broader (2)

OxadiazolesVasodilator Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
[Severe cytolytic hepatitis caused by imolamine].
1980
1980
[Imolamine in ischemic cardiopathy: results of a study of platelet aggregation in vitro and ex vivo].
1980
1980
[An assessment of the antianginous and metabolic effects of imolamine (author's transl)].
1979
1979
Platelet antiaggregating activity of imolamine: in vitro studies.
1978
1978
[Haemodynamic effects of imolamine (author's transl)].
1977
1977
[The use of imolamine in intravenous administration is ischemic cardiopathy].
1976
1976
[Imolamine in myocardial infarct: various considerations on 34 treated cases].
1975
1975
[The effects of imolamine on auriculo-ventricular conduction by recoil of His potential].
The electropharmacological action of imolamine was studied using Hiss bundle electrography. In dogs with spontaneous sinusal… 
1974
1974
Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
1969
1969
Effect of aminophylline, butalamine and imolamine on human isolated smooth muscle
Butalamine, (3-phenyl-5-dibutylaminoethyl-amino1,2,4-oxadiazole) and imolamine, (3-phenyl5-imino-4-diethylaminoethyl-l,2,4… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)